1
|
Barker M, Günther A, Wurps H, Gebhardt A, Schönfeld N, Polsfuss S, Bauer TT. Ultrasound-guided lymph node biopsy in smear-negative children and adolescents with suspected TB. Int J Tuberc Lung Dis 2023; 27:164-165. [PMID: 36853115 DOI: 10.5588/ijtld.22.0364] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023] Open
Affiliation(s)
- M Barker
- Department of Paediatrics, Helios Klinikum Emil von Behring, Berlin, Germany
| | - A Günther
- Department of Paediatrics, Helios Klinikum Emil von Behring, Berlin, Germany
| | - H Wurps
- Department of Respiratory Medicine, Heckeshorn Lung Unit, Helios Klinikum Emil von Behring, Berlin, Germany
| | - A Gebhardt
- Department of Respiratory Medicine, Heckeshorn Lung Unit, Helios Klinikum Emil von Behring, Berlin, Germany
| | - N Schönfeld
- Department of Respiratory Medicine, Heckeshorn Lung Unit, Helios Klinikum Emil von Behring, Berlin, Germany
| | - S Polsfuss
- Institute for Microbiology, Immunology and Laboratory Medicine, Helios Klinikum Emil von Behring, Berlin, Germany
| | - T T Bauer
- Department of Respiratory Medicine, Heckeshorn Lung Unit, Helios Klinikum Emil von Behring, Berlin, Germany, German Central Committee for the Fight against Tuberculosis (DZK), Berlin, Germany
| |
Collapse
|
2
|
Otto-Knapp R, Häcker B, Breuer C, Diel R, Kaufmann SHE, Korr G, Pfeiffer M, Schaberg T, Schönfeld N, Witte P, Bauer T. [DZK Recommendations for Tuberculosis, BCG and COVID-19 in Germany - (Official Abbreviation of Coronavirus Disease 2019 Caused by the New Coronavirus SARS-CoV-2)]. Pneumologie 2020; 74:412-416. [PMID: 32674189 DOI: 10.1055/a-1199-6721] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Affiliation(s)
- R Otto-Knapp
- Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose e. V. (DZK)
| | - B Häcker
- Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose e. V. (DZK)
| | - C Breuer
- Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose e. V. (DZK).,Gesundheitsamt Dresden, Dresden
| | - R Diel
- Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose e. V. (DZK).,LungenClinic Grosshansdorf, Airway Disease Center North (ARCN), Großhansdorf
| | | | - G Korr
- Bundesministerium für Gesundheit, Berlin
| | - M Pfeiffer
- Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose e. V. (DZK).,Klinik Donaustauf, Universitätsklinikum Regensburg, Regensburg.,Deutsche Gesellschaft für Pneumologie e. V. (DGP)
| | - T Schaberg
- Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose e. V. (DZK)
| | - N Schönfeld
- Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose e. V. (DZK).,Helios Klinikum Emil von Behring, Lungenklinik Heckeshorn, Berlin
| | - P Witte
- Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose e. V. (DZK).,Institut für Krankenhaushygiene der Mühlenkreiskliniken, Universitätsklinikum Johannes-Wesling Minden
| | - T Bauer
- Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose e. V. (DZK).,Deutsche Gesellschaft für Pneumologie e. V. (DGP).,Helios Klinikum Emil von Behring, Lungenklinik Heckeshorn, Berlin
| |
Collapse
|
3
|
Koch G, Schönfeld N, Jost K, Atkinson A, Schulzke SM, Pfister M, Datta AN. Caffeine preserves quiet sleep in preterm neonates. Pharmacol Res Perspect 2020; 8:e00596. [PMID: 32412185 PMCID: PMC7227120 DOI: 10.1002/prp2.596] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2020] [Revised: 03/24/2020] [Accepted: 03/26/2020] [Indexed: 12/17/2022] Open
Abstract
Caffeine is widely used in preterm neonates suffering from apnea of prematurity (AOP), and it has become one of the most frequently prescribed medications in neonatal intensive care units. Goal of this study is to investigate how caffeine citrate treatment affects sleep-wake behavior in preterm neonates. The observational study consists of 64 preterm neonates during their first 5 days of life with gestational age (GA) <32 weeks or very low birthweight of < 1500 g. A total of 52 patients treated with caffeine citrate and 12 patients without caffeine citrate were included. Sleep-wake behavior was scored in three stages: active sleep, quiet sleep, and wakefulness. Individual caffeine concentration of every neonate was simulated with a pharmacokinetic model. In neonates with GA ≥ 28 weeks, wakefulness increased and active sleep decreased with increasing caffeine concentrations, whereas quiet sleep remained unchanged. In neonates with GA < 28 weeks, no clear caffeine effects on sleep-wake behavior could be demonstrated. Caffeine increases fraction of wakefulness, alertness, and most probably also arousability at cost of active but not quiet sleep in preterm neonates. As such, caffeine should therefore not affect time for physical and cerebral regeneration during sleep in preterm neonates.
Collapse
Affiliation(s)
- Gilbert Koch
- Pediatric Pharmacology and Pharmacometrics Research CenterUniversity Children’s Hospital Basel (UKBB)BaselSwitzerland
| | - Natalie Schönfeld
- Pediatric Pharmacology and Pharmacometrics Research CenterUniversity Children’s Hospital Basel (UKBB)BaselSwitzerland
| | - Kerstin Jost
- Department of NeonatologyUniversity Children’s Hospital Basel (UKBB)BaselSwitzerland
| | - Andrew Atkinson
- Pediatric Pharmacology and Pharmacometrics Research CenterUniversity Children’s Hospital Basel (UKBB)BaselSwitzerland
| | - Sven M. Schulzke
- Department of NeonatologyUniversity Children’s Hospital Basel (UKBB)BaselSwitzerland
| | - Marc Pfister
- Pediatric Pharmacology and Pharmacometrics Research CenterUniversity Children’s Hospital Basel (UKBB)BaselSwitzerland
- Quantitative Solutions a Certara CompanyPrincetonNJUSA
| | - Alexandre N. Datta
- Department of Pediatric Neurology and Developmental MedicineUniversity Children’s Hospital Basel (UKBB)BaselSwitzerland
| |
Collapse
|
4
|
Behr J, Günther A, Bonella F, Dinkel J, Fink L, Geiser T, Geißler K, Gläser S, Handzhhiev S, Jonigk D, Koschel D, Kreuter M, Leuschner G, Markart P, Prasse A, Schönfeld N, Schupp JC, Sitter H, Müller-Quernheim J, Costabel U. [German Guideline for Idiopathic Pulmonary Fibrosis]. Pneumologie 2020; 74:e1-e2. [PMID: 32422671 DOI: 10.1055/a-1179-2905] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Affiliation(s)
- J Behr
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München und Asklepios Fachkliniken München-Gauting, Comprehensive Pneumology Center, Mitglied des Deutschen Zentrums für Lungenforschung, München
| | - A Günther
- Schwerpunkt Fibrosierende Lungenerkrankungen, Universitätsklinikum Gießen - Marburg, Standort Gießen, Justus-Liebig-Universität Gießen, sowie Agaplesion Pneumologische Klinik Waldhof-Elgershausen, Greifenstein, University of Giessen Marburg Lung Center, Mitglied des Deutschen Zentrums für Lungenforschung
| | - F Bonella
- Zentrum für interstitielle und seltene Lungenkrankheiten, Klinik für Pneumologie, Ruhrlandklinik, Universitätsmedizin Essen, Essen
| | - J Dinkel
- Klinik für Radiologie, Klinikum der Universität München, LMU, und Asklepios Fachkliniken München Gauting, Mitglied des Deutschen Zentrums für Lungenforschung (DZL)
| | - L Fink
- Institut für Pathologie und Zytologie, ÜGP Wetzlar, Mitglied des Deutschen Zentrums für Lungenforschung, Wetzlar
| | - T Geiser
- Universitätsklinik für Pneumologie, Universitätsspital, Universität Bern, Bern
| | - K Geißler
- Patientenvertretung Lungenfibrose e. V., Essen
| | - S Gläser
- Vivantes Klinikum Neukölln und Spandau Berlin, Klinik für Innere Medizin - Pneumologie und Infektiologie sowie und Universitätsmedizin Greifswald, Greifswald
| | - S Handzhhiev
- Klinische Abteilung für Pneumologie, Universitätsklinikum Krems, Krems an der Donau, Österreich
| | - D Jonigk
- Institut für Pathologie, Medizinische Hochschule Hannover, Mitglied des Deutschen Zentrums für Lungenforschung, Hannover
| | - D Koschel
- Abteilung Innere Medizin/Pneumologie, Fachkrankenhaus Coswig, Zentrum für Pneumologie, Allergologie, Beatmungsmedizin, Thoraxchirurgie und Medizinische Klinik 1, Bereich Pneumologie, Universitätsklinikum Carl Gustav Carus, Dresden
| | - M Kreuter
- Zentrum für interstitielle und seltene Lungenerkrankungen, Pneumologie und Beatmungsmedizin, Thoraxklinik, Universitätsklinikum Heidelberg, Mitglied des Deutschen Zentrums für Lungenforschung, Heidelberg
| | - G Leuschner
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München und Asklepios Fachkliniken München-Gauting, Comprehensive Pneumology Center, Mitglied des Deutschen Zentrums für Lungenforschung, München
| | - P Markart
- Schwerpunkt Fibrosierende Lungenerkrankungen, Universitätsklinikum Gießen - Marburg, Standort Gießen, Justus-Liebig-Universität Gießen, University of Giessen Marburg Lung Center, sowie Campus Fulda Universitätsmedizin Marburg, Med. Klinik V; Mitglied des Deutschen Zentrums für Lungenforschung, Fulda
| | - A Prasse
- Klinik für Pneumologie, Medizinische Hochschule Hannover und Clinical Research Center Fraunhofer Institut ITEM, Mitglied des Deutschen Zentrums für Lungenforschung, Hannover
| | - N Schönfeld
- Klinik für Pneumologie, Lungenklinik Heckeshorn, Helios Klinikum Emil von Behring, Berlin
| | - J C Schupp
- Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, Yale University, New Haven, Connecticut, United States
| | - H Sitter
- Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), Berlin
| | - J Müller-Quernheim
- Klinik für Pneumologie, Department Innere Medizin, Medizinische Fakultät, Albert Ludwigs Universität, Freiburg
| | - U Costabel
- Zentrum für interstitielle und seltene Lungenkrankheiten, Klinik für Pneumologie, Ruhrlandklinik, Universitätsmedizin Essen, Essen
| |
Collapse
|
5
|
Behr J, Günther A, Bonella F, Dinkel J, Fink L, Geiser T, Geißler K, Gläser S, Handzhhiev S, Jonigk D, Koschel D, Kreuter M, Leuschner G, Markart P, Prasse A, Schönfeld N, Schupp JC, Sitter H, Müller-Quernheim J, Costabel U. [German Guideline for Idiopathic Pulmonary Fibrosis]. Pneumologie 2020; 74:263-293. [PMID: 32227328 DOI: 10.1055/a-1120-3531] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
Idiopathic pulmonary fibrosis (IPF) is a severe and often fatal disease. Diagnosis of IPF requires considerable expertise and experience. Since publication of the international IPF guideline in the year 2011 and Update 2018 several studies and technical advances occurred, which made a new assessment of the diagnostic process mandatory. In view of the antifibrotic drugs which have been approved for the treatment of IPF patients, the goal of this guideline is to foster early, confident and effective diagnosis of IPF. The guideline focusses on the typical clinical setting of an IPF patient and provides tools to exclude known causes of interstitial lung disease including standardised questionnaires, serologic testing and cellular analysis of bronchoalveolar lavage. High resolution computed tomography remains crucial in the diagnostic work-up. If it is necessary to obtain specimen for histology transbronchial lung cryobiopsy is the primary approach, while surgical lung biopsy is reserved for patients who are fit for it and in whom bronchoscopic diagnosis did not provide the information needed. Despite considerable progress, IPF remains a diagnosis of exclusion and multidisciplinary discussion remains the golden standard of diagnosis.
Collapse
Affiliation(s)
- J Behr
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München und Asklepios Fachkliniken München-Gauting, Comprehensive Pneumology Center, Mitglied des Deutschen Zentrums für Lungenforschung, München
| | - A Günther
- Schwerpunkt Fibrosierende Lungenerkrankungen, Universitätsklinikum Gießen - Marburg, Standort Gießen, Justus-Liebig-Universität Gießen, sowie Agaplesion Pneumologische Klinik Waldhof-Elgershausen, Greifenstein, University of Giessen Marburg Lung Center, Mitglied des Deutschen Zentrums für Lungenforschung
| | - F Bonella
- Zentrum für interstitielle und seltene Lungenkrankheiten, Klinik für Pneumologie, Ruhrlandklinik, Universitätsmedizin Essen, Essen
| | - J Dinkel
- Klinik für Radiologie, Klinikum der Universität München, LMU, und Asklepios Fachkliniken München Gauting, Mitglied des Deutschen Zentrums für Lungenforschung (DZL)
| | - L Fink
- Institut für Pathologie und Zytologie, ÜGP Wetzlar, Mitglied des Deutschen Zentrums für Lungenforschung, Wetzlar
| | - T Geiser
- Universitätsklinik für Pneumologie, Universitätsspital, Universität Bern, Bern
| | - K Geißler
- Patientenvertretung Lungenfibrose e. V., Essen
| | - S Gläser
- Vivantes Klinikum Neukölln und Spandau Berlin, Klinik für Innere Medizin - Pneumologie und Infektiologie sowie und Universitätsmedizin Greifswald, Greifswald
| | - S Handzhhiev
- Klinische Abteilung für Pneumologie, Universitätsklinikum Krems, Krems an der Donau, Österreich
| | - D Jonigk
- Institut für Pathologie, Medizinische Hochschule Hannover, Mitglied des Deutschen Zentrums für Lungenforschung, Hannover
| | - D Koschel
- Abteilung Innere Medizin/Pneumologie, Fachkrankenhaus Coswig, Zentrum für Pneumologie, Allergologie, Beatmungsmedizin, Thoraxchirurgie und Medizinische Klinik 1, Bereich Pneumologie, Universitätsklinikum Carl Gustav Carus, Dresden
| | - M Kreuter
- Zentrum für interstitielle und seltene Lungenerkrankungen, Pneumologie und Beatmungsmedizin, Thoraxklinik, Universitätsklinikum Heidelberg, Mitglied des Deutschen Zentrums für Lungenforschung, Heidelberg
| | - G Leuschner
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München und Asklepios Fachkliniken München-Gauting, Comprehensive Pneumology Center, Mitglied des Deutschen Zentrums für Lungenforschung, München
| | - P Markart
- Schwerpunkt Fibrosierende Lungenerkrankungen, Universitätsklinikum Gießen - Marburg, Standort Gießen, Justus-Liebig-Universität Gießen, University of Giessen Marburg Lung Center, sowie Campus Fulda Universitätsmedizin Marburg, Med. Klinik V; Mitglied des Deutschen Zentrums für Lungenforschung, Fulda
| | - A Prasse
- Klinik für Pneumologie, Medizinische Hochschule Hannover und Clinical Research Center Fraunhofer Institut ITEM, Mitglied des Deutschen Zentrums für Lungenforschung, Hannover
| | - N Schönfeld
- Klinik für Pneumologie, Lungenklinik Heckeshorn, Helios Klinikum Emil von Behring, Berlin
| | - J C Schupp
- Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, Yale University, New Haven, Connecticut, United States
| | - H Sitter
- Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), Berlin
| | - J Müller-Quernheim
- Klinik für Pneumologie, Department Innere Medizin, Medizinische Fakultät, Albert Ludwigs Universität, Freiburg
| | - U Costabel
- Zentrum für interstitielle und seltene Lungenkrankheiten, Klinik für Pneumologie, Ruhrlandklinik, Universitätsmedizin Essen, Essen
| |
Collapse
|
6
|
Maurer FP, Bauer T, Diel R, Häcker B, Lange C, Niemann S, Otto-Knapp R, Schönfeld N. [Joint Statement on the New WHO Recommendations for Treatment of Multidrug- and Rifampicin-Resistant Tuberculosis]. Pneumologie 2019; 73:270-273. [PMID: 31083750 DOI: 10.1055/a-0880-9987] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Affiliation(s)
- F P Maurer
- Nationales Referenzzentrum für Mykobakterien, Forschungszentrum Borstel, Leibniz Lungenzentrum, Borstel
| | - T Bauer
- Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose (DZK e. V.), Berlin.,Klinik für Pneumologie, Lungenklinik Heckeshorn, Helios Klinikum Emil von Behring, Berlin
| | - R Diel
- Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose (DZK e. V.), Berlin.,LungenClinic Großhansdorf, Großhansdorf
| | - B Häcker
- Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose (DZK e. V.), Berlin.,Klinik für Pneumologie, Lungenklinik Heckeshorn, Helios Klinikum Emil von Behring, Berlin
| | - C Lange
- Nationales Referenzzentrum für Mykobakterien, Forschungszentrum Borstel, Leibniz Lungenzentrum, Borstel.,Deutsches Zentrum für Infektionsforschung (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Borstel
| | - S Niemann
- Nationales Referenzzentrum für Mykobakterien, Forschungszentrum Borstel, Leibniz Lungenzentrum, Borstel.,Deutsches Zentrum für Infektionsforschung (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Borstel
| | - R Otto-Knapp
- Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose (DZK e. V.), Berlin
| | - N Schönfeld
- Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose (DZK e. V.), Berlin.,Klinik für Pneumologie, Lungenklinik Heckeshorn, Helios Klinikum Emil von Behring, Berlin
| |
Collapse
|
7
|
Othmer J, Schönfeld N, Häcker B, Otto-Knapp R, Bauer T. Migration und Tuberkulose. Pneumologie 2018; 72:644-659. [DOI: 10.1055/s-0043-118435] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
8
|
Wurps H, Schönfeld N, Bauer TT, Bock M, Duve C, Sauer R, Mairinger T, Griff S. Intra-patient comparison of parietal pleural biopsies by rigid forceps, flexible forceps and cryoprobe obtained during medical thoracoscopy: a prospective series of 80 cases with pleural effusion. BMC Pulm Med 2016; 16:98. [PMID: 27387441 PMCID: PMC4937596 DOI: 10.1186/s12890-016-0258-5] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2016] [Accepted: 06/06/2016] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND There is only few data available on the use of cryotechnique during medical thoracoscopy. METHODS Medical thoracoscopy was performed in consecutive patients with pleural effusion. Prospectively, biopsies were taken by rigid forceps, flexible forceps and cryoprobe. Specimen size, depth and diagnostic yield were compared. RESULTS 80 Patients were included. 408 biopsies were taken (205 rigid biopsies, 104 flexible biopsies, 99 cryobiopsies). Mean surface area of rigid biopsies was 22.6 ± 20.4 mm(2) (flexible biopsies: 7.1 ± 9.3 mm(2), cryobiopsies: 14.4 ± 12.8 mm(2)). Rigid biopsies were significantly larger than cryobiopsies (p < 0.001) and flexible biopsies (p < 0.001), crybiopsies were significantly larger than flexible biopsies (p < 0.01). A deep biopsy containing fatty tissue was harvested in 63 % of rigid biopsies (cryobiopsy: 49.5 % flexible biopsy: 39.5 %). In 79/80 cases (98.7 % 95 % CI cannot be calculated) a diagnosis was obtained by rigid biopsy (cryobiopsy: 73/80 cases (91.3 % 95 % CI 86.0 - 96.5 %), flexible biopsy: 74/80 cases (92.5 % 95 % CI 88.6 - 97.4 %)). Diagnostic yield achieved with cryobiopsies was inferior to the yield of rigid biopsies (Difference: 12.7 %), but non-inferior to flexible biopsies (Difference: 6.5 %). CONCLUSION Cryobiopsies in medical thoracoscopy are safe with high diagnostic yield, non-inferior to flexible biopsies with increased tissue quantity and quality. Cryotechnique can develop an important role in medical thoracoscopy in the near future when rigid thoracoscopy is not available.
Collapse
Affiliation(s)
- H Wurps
- Department of Respiratory Medicine, Lungenklinik Heckeshorn, HELIOS Klinikum Emil von Behring, Berlin, Germany.
| | - N Schönfeld
- Department of Respiratory Medicine, Lungenklinik Heckeshorn, HELIOS Klinikum Emil von Behring, Berlin, Germany
| | - T T Bauer
- Department of Respiratory Medicine, Lungenklinik Heckeshorn, HELIOS Klinikum Emil von Behring, Berlin, Germany
| | - M Bock
- Department of Respiratory Medicine, Lungenklinik Heckeshorn, HELIOS Klinikum Emil von Behring, Berlin, Germany
| | - C Duve
- Department of Respiratory Medicine, Lungenklinik Heckeshorn, HELIOS Klinikum Emil von Behring, Berlin, Germany
| | - R Sauer
- Department of Pneumology and Institute of Pathology, HELIOS Klinikum Emil von Behring, Berlin, Germany
| | - T Mairinger
- Department of Pneumology and Institute of Pathology, HELIOS Klinikum Emil von Behring, Berlin, Germany
| | - S Griff
- Department of Pneumology and Institute of Pathology, HELIOS Klinikum Emil von Behring, Berlin, Germany
| |
Collapse
|
9
|
Ammenwerth W, Crolow C, Wurps H, Schultz T, Krüll M, Ukas K, Schönfeld N, Blum TG, Bauer TT. [Pneumology and Sports: An Outpatient Endurance Training with Sports Medical Guidance as an Effective Non-pharmacological Therapy in Pneumology - a Feasibility Study]. Pneumologie 2016; 70:314-9. [PMID: 26956576 DOI: 10.1055/s-0042-102299] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Abstract
BACKGROUND In the process of medical rehabilitation muscular endurance training is the main focus. Unfortunately, outpatient rehabilitation opportunities are limited and specialized pulmonary exercise groups ("lung sport groups") rarely available. Therefore we developed an outpatient endurance sports program for patients with respiratory diseases and evaluated its effectiveness. METHODS In this feasibility study 31 patients (50 ± 15 years) with diverse respiratory diseases were included. By professional functional exercise testing (incl. CPET and lactate measurement according to the standards of DGP and DGSP) the patients optimal training zone was determined and an individualized 12 week lasting aerobic endurance training with ≥ 3 sessions of 20 - 60 min/week realized. RESULTS After completion of the exercise training program a significant improvement in dyspnoea (Borg-Scale: 65.7 ± 12.2 vs. 62.2 ± 12.6, p = 0.013), body constitution (BMI: 25.7 ± 3.3 vs. 24.3 ± 3.2 kg/m(2), p = 0.018; portion of body fat: 24.8 ± 5.8 vs. 23.8 ± 6.4 %, p = 0.043) as well as physical capacity (VO2 at 4 mmol/l Laktat: 24.2 ± 6.9 vs. 26.5 ± 7.6 ml/min/kg, p < 0.01; performance at 4 mmol/l Laktat: running/walking (n = 14) + 1.1 km/h, p = 0.018 and biking/bicycle ergometer (n = 17) + 8.7 Watt, p = 0.019) was recorded. These positive developments were also observed in mental and physical quality of life (quality of life questionnaire SF-36: physical score + 9.7 points, mental score + 4.5 points). CONCLUSION The evaluated exercise program can easily be trained by the patient in a self-dependent setting and was seen to be an effective sports medical treatment in patients with diverse pulmonary diseases.
Collapse
Affiliation(s)
- W Ammenwerth
- Pneumologische Gemeinschaftspraxis Schmitz/Wiegemann/Ammenwerth, Bochum
| | - C Crolow
- Klinik für Pneumologie, Lungenklinik Heckeshorn, Helios Klinikum Emil von Behring, Berlin
| | - H Wurps
- Klinik für Pneumologie, Lungenklinik Heckeshorn, Helios Klinikum Emil von Behring, Berlin
| | - Th Schultz
- Pneumologische Gemeinschaftspraxis Lichterfelde, Berlin
| | - M Krüll
- SMS-Sportmedizin Berlin, Berlin
| | - K Ukas
- Klinik für Pneumologie, Lungenklinik Heckeshorn, Helios Klinikum Emil von Behring, Berlin
| | - N Schönfeld
- Klinik für Pneumologie, Lungenklinik Heckeshorn, Helios Klinikum Emil von Behring, Berlin
| | - T G Blum
- Klinik für Pneumologie, Lungenklinik Heckeshorn, Helios Klinikum Emil von Behring, Berlin
| | - T T Bauer
- Klinik für Pneumologie, Lungenklinik Heckeshorn, Helios Klinikum Emil von Behring, Berlin
| |
Collapse
|
10
|
Behr J, Bonella F, Bonnet R, Gläser S, Grohé C, Günther A, Koschel D, Kreuter M, Kirsten D, Krögel C, Markart P, Müller-Quernheim J, Neurohr C, Pfeifer M, Prasse A, Schönfeld N, Schreiber J, Wirtz H, Witt C, Costabel U. [Position Paper: Significance of the Forced Vital Capacity in Idiopathic Pulmonary Fibrosis]. Pneumologie 2015; 69:455-8. [PMID: 26227628 DOI: 10.1055/s-0034-1392602] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
Spirometry is a highly standardized method which allows to measure the forced vital capacity (FVC) with high precision and reproducibility. In patients with IPF FVC is directly linked to the disease process which is characterized by scaring of alveoli and shrinkage of the lungs. Consequently, there is ample evidence form clinical studies that the decline of FVC over time is consistently associated with mortality in IPF. As for the first time effective drugs for the treatment of IPF are available it becomes obvious that in studies which could demonstrate that the drug reduces FVC decline, a numerical effect on mortality was also observed, while in one study where a significant effect on FVC decline was missed, there was also no change in mortality. Based on these studies FVC decline is a validated surrogate of mortality in IPF. It is concluded that FVC decline is not only accepted as an endpoint of clinical treatment trials in IPF but is also valid as a patient related outcome parameter which should be considered for the assessment of the efficacy of an IPF drug.
Collapse
Affiliation(s)
- J Behr
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München und Asklepios Fachkliniken München-Gauting, Comprehensive Pneumology Center, Mitglied des Deutschen Zentrums für Lungenforschung
| | - F Bonella
- Ruhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen gGmbH
| | - R Bonnet
- Abteilung Pneumologie, Zentralklinik Bad Berka GmbH
| | - S Gläser
- Klinik für Innere Medizin B - Bereich Pneumologie, Infektiologie und Weaningzentrum Forschungsbereich Pneumologie und Pneumologische Epidemiologie Universitätsmedizin Greifswald
| | - C Grohé
- Pneumologische Klinik Evangelische Lungenklinik Berlin - Krankenhausbetriebs gGmbH
| | - A Günther
- Medizinische Klinik III, Pneumologie und Internistische Intensivmedizin Agaplesion Evangelisches Krankenhaus Mittelhessen und Schwerpunkt "Fibrosierende Lungenerkrankungen", Universitätsklinikum Gießen Marburg GmbH, Mitglied des Deutschen Zentrums für Lungenforschung
| | - D Koschel
- Abteilung Innere Medizin/Pneumologie, Fachkrankenhaus Coswig GmbH Zentrum für Pneumologie, Allergologie, Beatmungsmedizin, Thorax- und Gefäßchirurgie
| | - M Kreuter
- Pneumologie und Beatmungsmedizin, Zentrum für seltene und interstitielle Lungenerkrankungen Thoraxklinik, Universitätsklinikum Heidelberg, Mitglied des Deutschen Zentrums für Lungenforschung
| | | | - C Krögel
- Abteilung Pneumologie & Allergologie/Immunologie, Medizinische Klinik I, Klinikum der Universität Jena
| | - P Markart
- Medizinische Klinik und Poliklinik II, Universitätsklinikum Gießen und Marburg GmbH, Standort Gießen und Medizinische Klinik V (Pneumologie), Herz-Thorax-Zentrum, Klinikum Fulda gAG
| | | | - C Neurohr
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Comprehensive Pneumology Center, Mitglied des Deutschen Zentrums für Lungenforschung
| | - M Pfeifer
- Klinik Donaustauf, Klinik für Pneumologie und konservative Intensivmedizin Krankenhaus Barmherzige Brüder, Regensburg, Klinik und Poliklinik für Innere Medizin II Universität Regensburg
| | - A Prasse
- Abteilung Pneumologie, Medizinische Hochschule Hannover
| | - N Schönfeld
- Klinik für Pneumologie, Lungenklinik Heckeshorn, HELIOS Klinikum Emil von Behring, Berlin
| | - J Schreiber
- Klinik für Pneumologie, Universitätsklinikum der Otto-von-Guericke-Universität, Magdeburg
| | - H Wirtz
- Abteilung Pneumologie, Universitätsklinikum Leipzig
| | - C Witt
- Abteilung Pneumologie und Transplantation, Universitätsklinikum Charité, Berlin
| | - U Costabel
- Senior Consultant, Interstitielle und Seltene Lungenkrankheiten, Ruhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen gGmbH
| |
Collapse
|
11
|
Bös L, Schönfeld N, Schaberg T. Nichttuberkulöse Mykobakterien – eine kurze Übersicht zur Epidemiologie, Diagnostik und Therapie. Pneumologie 2015; 69:287-93; quiz 294. [DOI: 10.1055/s-0034-1391971] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Affiliation(s)
- L. Bös
- Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose (DZK e.V.), Auf dem Gelände des Helios Klinikums Emil von Behring, Berlin
| | - N. Schönfeld
- Klinik für Pneumologie der Lungenklinik Heckeshorn, Helios Klinikum Emil von Behring, Berlin
| | - T. Schaberg
- Zentrum für Pneumologie – Agaplesion Diakonieklinikum Rotenburg
| |
Collapse
|
12
|
Delis S, Nehls W, Crolow C, Black NB, Schönfeld N, Bauer TT. Die Palliativstation für COPD-Patienten – ein Wegbereiter. Pneumologie 2015. [DOI: 10.1055/s-0035-1544796] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
13
|
Krieger D, Vesenbeckh S, Schönfeld N, Bettermann G, Bauer TT, Rüssmann H, Mauch H. Auf der Suche nach Reservemedikamenten zur Behandlung der MDR-Tuberkulose: Minimale Hemmkonzentrationen (MHKs) der in vitro-Aktivität des Malariamedikamentes Mefloquine. Pneumologie 2015. [DOI: 10.1055/s-0035-1544805] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
14
|
Misch D, Crolow C, Boch C, Thiel S, Blum T, Kollmeier J, Schönfeld N, Bauer TT. Chemotherapieansprechen jenseits der 3. Linie beim Nichtkleinzelligen Lungenkarzinom (NSCLC). Pneumologie 2015. [DOI: 10.1055/s-0035-1544737] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
15
|
Klein N, de With K, Lefman M, Schönfeld N, Rüssmann H, Bauer TT. Antibiotikaverbrauch in einer pneumologischen Klinik: Punkt-Prävalenz-Analyse zur Einschätzung von ABS (Antibiotic Stewardship)-Strategien. Pneumologie 2015. [DOI: 10.1055/s-0035-1544847] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
16
|
Vesenbeckh S, Krieger D, Schönfeld N, Bettermann G, Bauer TT, Rüssmann H, Mauch H. Minimale Hemmkonzentrationen (MHKs) der in vitro-Aktivität verschiedener Phenothiazin-Neuroleptika gegen M. tuberculosis. Pneumologie 2015. [DOI: 10.1055/s-0035-1544804] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
17
|
Martinelli M, Mauch H, Rüssmann H, Roth A, Schönfeld N, Bauer TT, Derwahl M, Gogoll C. Isoliert Moxifloxacin-resistente Tuberkulose – ein Fallbericht. Pneumologie 2015. [DOI: 10.1055/s-0035-1544806] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
18
|
Wurps H, Bock M, Sauer R, Schönfeld N, Blum T, Mairinger T, Griff S, Bauer TT. Kryobiopsie in der internistischen Thorakoskopie: eine sichere und diagnostisch wertvolle Methode. Pneumologie 2015. [DOI: 10.1055/s-0035-1544628] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
19
|
Otto-Knapp R, Streubel A, Roth A, Schönfeld N, Weiß T, Rüssmann H, Bauer TT, Mauch H. Molekularbiologische Resistenzbestimmung von Pyrazinamid im Vergleich zu konventionellen Methoden. Pneumologie 2015. [DOI: 10.1055/s-0035-1544807] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
20
|
Kümmerlen V, Schönfeld N, Roth A, Sabha T, Mauch H, Bauer TT, Rüssmann H. Pulmonale Mykobakteriose durch Mycobacterium peregrinum bei einem jungen Patienten mit Sichelzellanämie. Pneumologie 2015. [DOI: 10.1055/s-0035-1544838] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
21
|
Fléchet C, Schönfeld N, Blum TG, Griff S, Grosswendt C, Wurps H, Bittner R, Mairinger T, Bauer TT. Pulmonale Manifestationsformen differenzierter und undifferenzierter Autoimmunerkrankungen. Pneumologie 2015. [DOI: 10.1055/s-0035-1544814] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
22
|
Bock M, Wurps H, Mauch H, Roth A, Rüssmann H, Schönfeld N, Bauer TT. Histologische und kulturelle Ergebnisse ultraschallgestützter transbronchialer Lymphknotenpunktate bei Lymphadenitis tuberculosa. Pneumologie 2015. [DOI: 10.1055/s-0035-1544799] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
23
|
Vesenbeckh S, Wagner S, Mauch H, Roth A, Streubel A, Rüssmann H, Bauer TT, Matthiessen W, Schönfeld N. [Pathogenicity of Mycobacterium kansasii]. Pneumologie 2014; 68:526-31. [PMID: 25046682 DOI: 10.1055/s-0034-1377288] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
BACKGROUND In a recent prospective study on pulmonary infections with non-tuberculous mycobacteria (NTM) led by the WATL group, disease rates in patients with M. kansasii infection were found to be 100 %. In the present study we re-evaluated the pathogenicity of M. kansasii infections in a large lung diseases treatment center in Berlin (Lungenklinik Heckeshorn). METHODS All patients in whose respiratory specimen cultures M. kansasii was detected between January 2003 and June 2013 were included. The 2007 ATS diagnostic criteria were applied to differentiate disease from asymptomatic infection. The strains were further investigated by sequencing of the 16S-23S rDNA internal transcribed spacer (ITS) region. RESULTS We evaluated 43 consecutive cases. Complete patient data were available in 38 cases. In one patient, no culture results were obtained, in 37 patients M. kansasii was isolated and patient data could be retrieved. In 25/37 patients (68 %) clinical disease was present so that a specific treatment was initiated (underlying diseases were COPD in 8/25 (32 %), bronchiectasis in 5/25 (20 %), TB scar or scar due to prior chest surgery in 3/25 (12 %) and alcohol abuse in 4/25 (16 %)). Twelve out of 37 patients (32 %) were found to be colonized or asymptomatically infected (underlying diseases were COPD in 7/12 (58 %), bronchiectasis in 3/12 (25 %) and TB scar or scar due to prior chest surgery in 3/12 (25 %)). Sequencing results identified 30 strains as genotype I, and 2 strains as genotype II. In 22/30 cases (73 %) genotype I was considered pathogenic. CONCLUSIONS In our cohort, we could not confirm the high M. kansasii pathogenicity of 100 % found in a previous multi-center study; we therefore support the clinical and semiquantitative microbiologic diagnostic criteria also for infection with M. kansasii.
Collapse
Affiliation(s)
- S Vesenbeckh
- Klinik für Pneumologie, Lungenklinik Heckeshorn, Helios Klinikum Emil von Behring, Berlin
| | - S Wagner
- Institut für Mikrobiologie, Helios Klinikum Emil von Behring, Berlin
| | - H Mauch
- Institut für Mikrobiologie, Helios Klinikum Emil von Behring, Berlin
| | - A Roth
- ehemals Fachkrankenhaus Coswig
| | | | - H Rüssmann
- Institut für Mikrobiologie, Helios Klinikum Emil von Behring, Berlin
| | - T T Bauer
- Klinik für Pneumologie, Lungenklinik Heckeshorn, Helios Klinikum Emil von Behring, Berlin
| | - W Matthiessen
- Institut für Gewebediagnostik, Helios Klinikum Emil von Behring, Berlin
| | - N Schönfeld
- Klinik für Pneumologie, Lungenklinik Heckeshorn, Helios Klinikum Emil von Behring, Berlin
| |
Collapse
|
24
|
Otto-Knapp R, Bös L, Schönfeld N, Wagner S, Starzacher A, Weiss T, Vesenbeckh S, Glaser-Paschke G, Mauch H, Rüssmann H, Bauer T. Resistenzen gegen Zweitlinienmedikamente bei Migranten mit multiresistenter Tuberkulose in der Region Berlin. Pneumologie 2014; 68:496-500. [DOI: 10.1055/s-0034-1377226] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Affiliation(s)
- R. Otto-Knapp
- Lungenklinik Heckeshorn, HELIOS Klinikum Emil von Behring, Berlin
| | - L. Bös
- Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose (DZK), Berlin
| | - N. Schönfeld
- Lungenklinik Heckeshorn, HELIOS Klinikum Emil von Behring, Berlin
| | - S. Wagner
- Institut für Mikrobiologie, Immunologie und Laboratoriumsmedizin, HELIOS Klinikum Emil von Behring, Berlin
| | - A. Starzacher
- Lungenklinik Heckeshorn, HELIOS Klinikum Emil von Behring, Berlin
| | - T. Weiss
- Lungenklinik Heckeshorn, HELIOS Klinikum Emil von Behring, Berlin
| | - S. Vesenbeckh
- Lungenklinik Heckeshorn, HELIOS Klinikum Emil von Behring, Berlin
| | | | - H. Mauch
- Institut für Mikrobiologie, Immunologie und Laboratoriumsmedizin, HELIOS Klinikum Emil von Behring, Berlin
| | - H. Rüssmann
- Institut für Mikrobiologie, Immunologie und Laboratoriumsmedizin, HELIOS Klinikum Emil von Behring, Berlin
| | - T. Bauer
- Lungenklinik Heckeshorn, HELIOS Klinikum Emil von Behring, Berlin
| |
Collapse
|
25
|
Wildner N, Günther A, Mellerowicz H, Schönfeld N, Barker M. Vom Sportunfall zur Diagnose einer seltenen Systemerkrankung. Monatsschr Kinderheilkd 2014. [DOI: 10.1007/s00112-014-3095-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
26
|
Wirtz H, Kropp R, Behr J, Costabel U, Bonnet R, Schönfeld N, Prasse A, Kardos P, Seehausen V, Loddenkemper R. [50 years WATL (Scientific Working Group for the Therapy of Lung Diseases)]. Pneumologie 2014; 68:199-205. [PMID: 24595854 DOI: 10.1055/s-0034-1365237] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
On the occasion of the 50th anniversary of the Scientific Working Group for the Therapy of Lung Diseases (WATL) the history is described from its foundation to the present situation. Research topics during this long period are specified and the studies are briefly outlined. In the beginning, WATL was engaged mainly in studies on tuberculosis, later on, the spectrum of WATL was broadened considerably to diseases like sarcoidosis, pulmonary Langerhans' cell histiocytosis, pulmonary emphysema due to α1-antitrypsin deficiency, chronic obstructive bronchitis and bronchial asthma as well as nontuberculous mycobacterioses. Finally, realising that the methodological capabilities of WATL were not sufficient to conduct large trials in classical lung diseases considering current requirements, WATL has begun to acquire competence in rare lung diseases such as lymphangioleiomyomatosis and alveolar proteinosis. In addition, WATL is dedicated to educative aims by organising conferences on topics which are not part of main stream respiratory medicine.
Collapse
Affiliation(s)
- H Wirtz
- Abteilung Pneumologie, Universitätsklinikum Leipzig AöR
| | | | - J Behr
- Medizinische Klinik und Poliklinik V, Klinikum der Ludwig-Maximilians-Universität München
| | - U Costabel
- Abt. Pneumologie/Allergologie, Ruhrlandklinik, Universitätsklinik Essen
| | | | | | - A Prasse
- Klinik für Pneumologie, Universitätsklinikum Freiburg
| | - P Kardos
- Gemeinschaftspraxis Pneumologie, Klinik Maingau, Frankfurt/M
| | | | | |
Collapse
|
27
|
Krieger D, Schönfeld N, Otto-Knapp R, Starzacher K, Blum TG, Mauch H, Rüssmann H, Bauer TT. Erste Erfahrungen mit Bedaquiline in der Behandlung von Patienten mit XDR-Tuberkulose. Pneumologie 2014. [DOI: 10.1055/s-0034-1367892] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
28
|
Wurps H, Sauer R, Schönfeld N, Ammenwerth W, Blum T, Mairinger T, Griff S, Bauer TT. Der diagnostische Wert der Kryobiopsie in der internistischen Thorakoskopie. Pneumologie 2014. [DOI: 10.1055/s-0034-1368023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
29
|
Schindler D, Wagner S, Schönfeld N, Rüssmann H, Bauer TT. Actinomyces graevenitzii: ein zunehmend als pathogen erkannter Erreger von Atemwegsinfektionen. Pneumologie 2014. [DOI: 10.1055/s-0034-1367853] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
30
|
Crolow C, Blum TG, Kollmeier J, Griff S, Thiel S, Weiß T, Schönfeld N, Rüssmann H, Bauer TT. Prognostische Bedeutung von Blutbildparametern und histologischem Subtyp beim malignen Pleuramesotheliom. Pneumologie 2014. [DOI: 10.1055/s-0034-1367982] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
31
|
Otto-Knapp R, Schönfeld N, Bös L, Wagner S, Roth A, Weiss T, Vesenbeckh S, Mauch H, Rüssmann H, Bauer TT. Minimale Hemmkonzentrationen für Isoniazid bei Mycobacterium tuberculosis Stämmen mit katG Mutation in der Lungenklinik Heckeshorn. Pneumologie 2014. [DOI: 10.1055/s-0034-1367896] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
32
|
Gastmeier A, Blum TG, Kollmeier J, Griff S, Thiel S, Nehls W, Sabha T, Schönfeld N, Mairinger M, Bauer TT. Prognostische Relevanz von histologischen Subtypen beim Lungenkarzinom – Überlebensanalysen bei häufigen und seltenen Entitäten. Pneumologie 2014. [DOI: 10.1055/s-0034-1367979] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
33
|
Blum T, Schicke B, Schönfeld N, Kollmeier J, Grohé C, Reinecke A. Alterskorrelation der Überlebenswahrscheinlichkeit von Patienten mit kleinzelligem Lungenkarzinom (SCLC). Pneumologie 2014. [DOI: 10.1055/s-0034-1367958] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
34
|
Grüning W, Ammenwerth W, Wurps H, Kollmeier J, Blum T, Schönfeld N, Griff S, Bauer TT. [Diagnostic yield and safety of bronchoscopic cryotechnique in routine diagnostics for suspected lung cancer]. Pneumologie 2013; 67:676-82. [PMID: 24222065 DOI: 10.1055/s-0033-1344853] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
BACKGROUND Cryoprobes with flexible catheters are an additional important tool for endobronchial interventional therapy and histologic diagnosis. Different studies compared the diagnostic effectiveness and complications to the forceps as a standard. However, routine endoscopic procedures require a combined use of different methods in order to achieve the highest diagnostic yield. We investigated the impact of cryotechnique in comparison with combined diagnostic tools during routine diagnostics of malignant tumors. PATIENTS AND METHODS A consecutive series of patients undergoing routine diagnostic for lung cancer was included over a 30 months period (n = 469). The use of the cryotechnique, the complication rates and diagnostic value were prospectively documented. Cryotechnique was used on top of conventional technologies. RESULTS A histologic proof of tumor by cryotechnique in centrally located tumors was delivered more frequently compared to forceps biopsies alone (81.4 versus 59.9% and 66.2 versus 37.7% in peripheral lesions). However, when the other non-cryotechniques were taken into account, the value was reduced in central probes (7.4%; p = 0.02), but remained high for peripheral findings (19.3%; p < 0.002). The frequency of complications seemed unchanged, however severe bleeding occurred. CONCLUSION The cryotechnique bears high diagnostic potential beside its therapeutic value, also in routine investigations. The changed complication profile of this technology needs to be addressed in the informed consent and secured airway management may be helpful.
Collapse
Affiliation(s)
- W Grüning
- Klinik für Pneumologie, HELIOS Klinikum Schwerin (Dr. W. Grüning)
| | | | | | | | | | | | | | | |
Collapse
|
35
|
Schönfeld N, Haas W, Richter E, Bauer T, Bös L, Castell S, Hauer B, Magdorf K, Matthiessen W, Mauch H, Reuß A, Rüsch-Gerdes S, Zabel P, Dalhoff K, Schaberg T, Loddenkemper R. Empfehlungen zur Diagnostik und Therapie nichttuberkulöser Mykobakteriosen des Deutschen Zentralkomitees zur Bekämpfung der Tuberkulose (DZK) und der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP). Pneumologie 2013; 67:605-33. [DOI: 10.1055/s-0033-1344790] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Affiliation(s)
- N. Schönfeld
- Klinik für Pneumologie, Lungenklinik Heckeshorn, HELIOS Klinikum Emil von Behring, Berlin
| | - W. Haas
- Abteilung für Infektionsepidemiologie, Fachgebiet für respiratorisch übertragbare Erkrankungen, Robert Koch-Institut, Berlin
| | - E. Richter
- Forschungszentrum Borstel, Nationales Referenzzentrum für Mykobakterien
| | - T. Bauer
- Klinik für Pneumologie, Lungenklinik Heckeshorn, HELIOS Klinikum Emil von Behring, Berlin
| | - L. Bös
- Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose, Berlin
| | - S. Castell
- Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose, Berlin
| | - B. Hauer
- Abteilung für Infektionsepidemiologie, Fachgebiet für respiratorisch übertragbare Erkrankungen, Robert Koch-Institut, Berlin
| | - K. Magdorf
- Klinik für Pädiatrie m. S. Pneumologie und Immunologie, Charité Universitätsmedizin Berlin
| | - W. Matthiessen
- Fachkrankenhaus Coswig, Zentrum für Pneumologie und Thoraxchirurgie
| | - H. Mauch
- Institut für Mikrobiologie, Immunologie und Laboratoriumsmedizin, HELIOS Klinikum Emil von Behring, Berlin
| | - A. Reuß
- Abteilung für Infektionsepidemiologie, Fachgebiet für respiratorisch übertragbare Erkrankungen, Robert Koch-Institut, Berlin
| | - S. Rüsch-Gerdes
- Forschungszentrum Borstel, Nationales Referenzzentrum für Mykobakterien
| | - P. Zabel
- Forschungszentrum Borstel, Medizinische Klinik
| | - K. Dalhoff
- Medizinische Klinik III, Universitätsklinikum Schleswig-Holstein, Campus Lübeck
| | - T. Schaberg
- Zentrum für Pneumologie, Agaplesion Diakonieklinikum Rotenburg
| | - R. Loddenkemper
- Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose, Berlin
| |
Collapse
|
36
|
Kreiter C, Streubel A, Roth A, Schönfeld N, Blum T, Bös L, Otto-Knapp R, Mauch H, Rüssmann H, Bauer TT, Mairinger T. Molekularbiologische Resistenzprüfung gegenüber Isoniazid und Rifampicin aus Direktmaterial von Tuberkulosepatienten. Pneumologie 2013. [DOI: 10.1055/s-0033-1334517] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
37
|
Vesenbeckh S, Schönfeld N, Wagner S, Mauch H, Rüssmann H, Kaiser D, Bauer TT. Pathogenität von Mycobacterium kansasii. Pneumologie 2013. [DOI: 10.1055/s-0033-1334747] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
38
|
Otto-Knapp R, Wagner S, Weiß T, Bös L, Vesenbeckh S, Glaser-Paschke G, Priwitzer M, Schönfeld N, Rüssmann H, Mauch H, Bauer TT. Empfindlichkeit der Zweitrangmedikamente bei Patienten mit MDR Tuberkulose. Monozentrische Ergebnisse von 2008 bis 2012. Pneumologie 2013. [DOI: 10.1055/s-0033-1334557] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
39
|
Sabha T, Schwitzke A, Ammenwerth W, Schönfeld N, Berliner M, Bauer TT. Einschränkungen der Kognition und Emotion bei älteren COPD-Patienten. Pneumologie 2013. [DOI: 10.1055/s-0033-1334793] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
40
|
Krieger D, Schönfeld N, Gößwald A, Kreiter C, Weiß T, Blum T, Rüssmann H, Mauch H, Bauer TT. Rezidivhäufigkeit bei immunkompetenten Patienten mit atypischer Mykobakteriose - Langzeitergebnisse eines monozentrischen Patientenkollektivs. Pneumologie 2013. [DOI: 10.1055/s-0033-1334518] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
41
|
Blum T, Schicke B, Schönfeld N, Jagota A. Versorgungssituation beim Lungenkarzinom in Deutschland - Ergebnisse einer Auswertung bundesweiter Daten klinischer Krebsregister. Pneumologie 2013. [DOI: 10.1055/s-0033-1334767] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
42
|
Brokat M, Wagner S, Blum T, Schönfeld N, Bauer TT, Rüssmann H. Späte beatmungsassoziierte Pneumonie (VAP) durch Carbapenemase-produzierendes Chryseobacterium gleum. Pneumologie 2013. [DOI: 10.1055/s-0033-1334746] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
43
|
Nehls W, Gabrijel S, Delis S, Blum T, Schönfeld N, Bauer TT. Auswirkungen eines Kommunikationstrainings in der Lungenklinik Heckeshorn auf die Kenntnisse und die Zufriedenheit von Lungenkarzinompatienten. Pneumologie 2013. [DOI: 10.1055/s-0033-1334707] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
44
|
Weiß T, Schönfeld N, Otto-Knapp R, Bös L, Bettermann G, Mauch H, Rüssmann H, Bauer TT. In vitro-Empfindlichkeitstestungen für Linezolid bei TB- und MDR-TB-Stämmen aus dem Patientenkollektiv eines regionalen Zentrums. Pneumologie 2013. [DOI: 10.1055/s-0033-1334558] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
45
|
Weidinger K, Kümmerlen V, Schönfeld N, Bauer TT, Griff S, Mairinger T, Kaiser D. Exophytisches intraluminales bronchiales Hamartochondrom. Pneumologie 2013. [DOI: 10.1055/s-0033-1334706] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
46
|
Ammenwerth W, Crolow C, Wurps H, Schönfeld N, Blum T, Bauer TT. Aerobes Ausdauertraining mit sportmedizinischer Anleitung als effektive ambulante pneumologische Rehabilitationsmaßnahme - eine Projektstudie. Pneumologie 2013. [DOI: 10.1055/s-0033-1334500] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
47
|
Crolow C, Ammenwerth W, Schönfeld N, Klemens M, Bittner RC, Bauer TT. Funktionelles Therapiemonitoring einer kardialen Sarkoidose mittels Spiroergometrie und Berechnung des Oxygen Uptake Efficiency Slope (OUES): ein Fallbericht. Pneumologie 2013. [DOI: 10.1055/s-0033-1334543] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
48
|
Wurps H, Griff S, Schönfeld N, Ammenwerth W, Blum T, Mairinger T, Bauer TT, Grüning W. Der diagnostische Wert der transbronchialen Kryobiopsie bei unklaren interstitiellen Lungenerkrankungen (ILE). Pneumologie 2013. [DOI: 10.1055/s-0033-1334581] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
49
|
Behr J, Günther A, Ammenwerth W, Bittmann I, Bonnet R, Buhl R, Eickelberg O, Ewert R, Gläser S, Gottlieb J, Grohé C, Kreuter M, Kroegel C, Markart P, Neurohr C, Pfeifer M, Prasse A, Schönfeld N, Schreiber J, Sitter H, Theegarten D, Theile A, Wilke A, Wirtz H, Witt C, Worth H, Zabel P, Müller-Quernheim J, Costabel U. [German guideline for diagnosis and management of idiopathic pulmonary fibrosis]. Pneumologie 2013; 67:81-111. [PMID: 23325398 DOI: 10.1055/s-0032-1326009] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
Idiopathic pulmonary fibrosis is a fatal lung disease with a variable and unpredictable natural history and limited treatment options. Since publication of the ATS-ERS statement on IPF in the year 2000 diagnostic standards have improved and a considerable number of randomized controlled treatment trials have been published necessitating a revision. In the years 2006 - 2010 an international panel of IPF experts produced an evidence-based guideline on diagnosis and treatment of IPF, which was published in 2011. In order to implement this evidence-based guideline into the German Health System a group of German IPF experts translated and commented the international guideline, also including new publications in the field. A consensus conference was held in Bochum on December 3rd 2011 under the protectorate of the "Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin (DGP)" and supervised by the "Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften" (AWMF). Most recommendations of the international guideline were found to be appropriate for the german situation. Based on recent clinical studies "weak negative" treatment recommendations for pirfenidone and anticoagulation were changed into "weak positive" for pirfenidone and "strong negative" for anticoagulation. Based on negative results from the PANTHER-trial the recommendation for the combination therapy of prednisone plus azathiorpine plus N-acetlycsteine was also changed into strong negative für patients with definite IPF. This document summarizes essential parts of the international IPF guideline and the comments and recommendations of the German IPF consensus conference.
Collapse
Affiliation(s)
- J Behr
- Asklepios Fachkliniken München-Gauting und Medizinische Klinik V, Klinikum der Ludwig-Maximilians-Universität München.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Blum T, Schönfeld N, Goeckenjan G, Jagota A. Umsetzung der S3-Leitlinie zur Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms im Land Berlin. Pneumologie 2012; 67:118-22. [DOI: 10.1055/s-0032-1325981] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Affiliation(s)
- T. Blum
- Klinik für Pneumologie, Lungenklinik Heckeshorn, HELIOS Klinikum Emil von Behring, Berlin
| | - N. Schönfeld
- Klinik für Pneumologie, Lungenklinik Heckeshorn, HELIOS Klinikum Emil von Behring, Berlin
| | | | | |
Collapse
|